phaclofen has been researched along with Benign Neoplasms, Brain in 1 studies
phaclofen: peripheral & central baclofen & GABA antagonist; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Phaclofen was about 700-fold less potent than CGP 52432 (IC50 = 70." | 1.29 | Characterization of the GABA autoreceptor in human neocortex as a pharmacological subtype of the GABAB receptor. ( Bonanno, G; Cavazzani, P; Fassio, A; Raiteri, M, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fassio, A | 1 |
| Bonanno, G | 1 |
| Cavazzani, P | 1 |
| Raiteri, M | 1 |
1 other study available for phaclofen and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Characterization of the GABA autoreceptor in human neocortex as a pharmacological subtype of the GABAB receptor.
Topics: Adolescent; Adult; Aged; Animals; Baclofen; Benzylamines; Binding, Competitive; Brain Neoplasms; Cer | 1994 |